Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
No single blood test confirms lupus, but a positive ANA (antinuclear antibody) test is the usual starting point, followed by more specific antibodies such as anti-dsDNA and anti-Smith, which are strongly associated with the disease. Doctors often add anti-Ro/SSA, anti-La/SSB, antiphospholipid antibodies, complement levels (C3 and C4), a complete blood count, ESR or CRP, and urinalysis to gauge inflammation and organ involvement. A butterfly-shaped (malar) rash across the cheeks and nose is suggestive, yet rosacea, seborrheic dermatitis, dermatomyositis, and drug reactions can look similar, so results are always interpreted alongside your symptoms and exam. There are important details about test accuracy, false positives, and what a negative ANA really means, so see below to understand more.
If you have a facial rash along with fatigue, joint pain, mouth sores, or sun sensitivity, a free, instant, online symptom check can help you organize your symptoms, see which conditions may fit, and understand which labs or specialist to ask about at your next visit.
Last reviewed for medical accuracy: 09/24/2026
A red, butterfly-shaped rash across the cheeks and bridge of the nose—often called a malar rash or lupus face rash—can be an early clue to systemic lupus erythematosus (SLE). However, a rash alone doesn’t confirm lupus. Blood tests play a critical role in supporting the diagnosis. Below is a clear guide to the key laboratory tests your doctor may order if you have a lupus face rash and suspected SLE.
What it is:
Why it’s ordered:
Key points:
If ANA is positive, your doctor may order these more specific tests:
Anti–double-stranded DNA (anti-dsDNA)
• Highly specific for SLE.
• Levels often correlate with disease activity, especially kidney involvement.
Anti-Smith (anti-Sm)
• Very specific but less common (present in ~25–30% of SLE patients).
• Strong diagnostic value.
Anti-Ro/SSA and Anti-La/SSB
• Seen in cutaneous lupus and Sjögren’s syndrome overlap.
• May predict photosensitivity and certain skin manifestations.
Anti-U1 RNP
• Associated with mixed connective tissue disease; sometimes positive in SLE.
What they are:
Why they’re ordered:
Key points:
Erythrocyte Sedimentation Rate (ESR)
• Nonspecific measure of inflammation.
• Often elevated during active SLE.
C-Reactive Protein (CRP)
• Less consistently elevated in lupus flares; marked rises may suggest infection rather than lupus alone.
What it covers:
Why it’s ordered:
Key findings:
Why it matters:
Tests include:
Medical history and exam:
Lab work:
Follow-up:
If you’re concerned about a lupus face rash or other symptoms, don’t wait. Early evaluation and treatment improve outcomes. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance before your visit.
Always speak to a doctor about any concerns. Blood tests can guide diagnosis, but clinical evaluation is essential. Your healthcare provider will interpret results in the context of your overall health and design a treatment plan tailored to you.
(References)
* Weigand DA. Cutaneous immunofluorescence. Med Clin North Am. 1989 Sep;73(5):1263-74. doi: 10.1016/s0025-7125(16)30633-2. PMID: 2671545.
* Tuffanelli DL. Lupus erythematosus. Arch Dermatol. 1972 Oct;106(4):553-66. PMID: 4344347.
* Kündig TM, Trüeb RM, Krasovec M. Lupus profundus/panniculitis. Dermatology. 1997;195(1):99-101. doi: 10.1159/000245706. PMID: 9267758.
* Marzano AV, Tavecchio S, Menicanti C, Crosti C. Drug-induced lupus erythematosus. G Ital Dermatol Venereol. 2014 Jun;149(3):301-9. PMID: 24819757.
* Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016 Nov 22;12(12):716-730. doi: 10.1038/nrrheum.2016.186. PMID: 27872476.
* Yokogawa N, Sumitomo N, Miura M, Shibuya K, Nagai H, Goto M, Murashima A. [Neonatal lupus erythematosus]. Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(2):124-130. doi: 10.2177/jsci.40.124. PMID: 28603203.
* Felten R, Lipsker D, Sibilia J, Chasset F, Arnaud L. The history of lupus throughout the ages. J Am Acad Dermatol. 2022 Dec;87(6):1361-1369. doi: 10.1016/j.jaad.2020.04.150. Epub 2020 May 4. PMID: 32380218.
* Montes-Torres A, García-Gil MF, Lanuza-Arcos R, Monte-Serrano J. Neonatal lupus. Med Clin (Barc). 2021 Dec 10;157(11):553. doi: 10.1016/j.medcli.2021.01.011. Epub 2021 Mar 24. PMID: 33773762.
* Ünlü B, Türsen Ü, Jabalameli N, Abdollahimajd F, Rajabi F. Immunogenetics of Lupus Erythematosus. Adv Exp Med Biol. 2022;1367:213-257. doi: 10.1007/978-3-030-92616-8_9. PMID: 35286698.
* Heil PM, Pittelkow MR, Weaver AL, Killian JM, Sokumbi O, Wetter DA. Systemic correlates of cutaneous manifestations of lupus erythematosus. Int J Dermatol. 2024 Aug;63(8):e148-e156. doi: 10.1111/ijd.17178. Epub 2024 May 10. PMID: 38727096.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.